Psychopharmacology of anxiety

Psychiatry

Volumn 3, Issue 4, 2004, Pages 11-15

  Nash, Jon ^a   Nutt, David J ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

anxiety; psychopharmacology

Indexed keywords

EID: 77949541892     PISSN: 14761793     EISSN: None     Source Type: Journal    
DOI: 10.1383/psyt.3.4.11.32907     Document Type: Article

References (15)

1. American Psychiatric Association. Practice Guidelines for the Treatment of Patients with Panic Disorder (1998), American Psychiatric Association, Washington, DC
2. Ballenger J.C., Davidson J.R., Lecrubier Y., et al. Consensus statement on panic disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry 59 Suppl 8 (1998) 47-54
3. Bandelow B., Zohar J., Hollander E., Kasper S., and Moller H.J. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders. World J Biol Psychiatry 3 (2002) 171-199
4. Barnett S.D., Kramer M.L., Casat C.D., Connor K.M., and Davidson J.R. Efficacy of olanzapine in social anxiety disorder: a pilot study. J Psychopharmacol 16 (2002) 365-368
5. Hertzberg M.A., Butterfield M.I., Feldman M.E., et al. A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder. Biol Psychiatry 45 (1999) 1226-1229
6. Nutt D.J. The unhappy saga of 'happy pills'. J Psychopharmacol 17 (2003) 251
7. Task Force Report of the American Psychiatric Association. Benzodiazepine Dependence, Toxicity, and Abuse (1990), American Psychiatric Association, Washington, DC
8. Williams D.D., and McBride A. Benzodiazepines: time for reassessment. Br J Psychiatry 173 (1998) 361-362
9. Ashton H., and Young A.H. GABA-ergic drugs: exit stage left, enter stage right. J Psychopharmacol 17 (2003) 174-178
10. Bell C.J., and Nutt D.J. Serotonin and panic. Br J Psychiatry 172 (1998) 465-471
11. Haddad P. The SSRI discontinuation syndrome. J Psychopharmacol 12 (1998) 305-313
12. Kent J.M., Mathew S.J., and Gorman J.M. Molecular targets in the treatment of anxiety. Biol Psychiatry 52 (2002) 1008-1030
13. In: Nutt D.J., and Ballenger J.C. (Eds). Anxiety Disorders (2003), Blackwell, Oxford
14. A-benzodiazepine receptor in psychiatric disorder. Br J Psychiatry 179 (2001) 390-396
15. Schweizer E., and Rickels K. Benzodiazepine dependence and withdrawal: a review of the syndrome and its clinical management. Acta Psychiatr Scand Suppl 393 (1998) 95-101